SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern
29 4월 2009 - 10:30PM
PR Newswire (US)
BOTHELL, Wash., April 29 /PRNewswire-FirstCall/ -- SCOLR Pharma,
Inc. (NYSE Alternext US: DDD) today announced plans to release
first quarter 2009 financial results on Friday, May 1, 2009, at
8:30 a.m. Eastern. Dr. Bruce S. Morra, President and CEO of SCOLR
Pharma, will host the conference call at 11:30 a.m. Eastern, to
discuss the Company's results for the quarter. Shareholders and
other interested parties may participate in the conference call by
dialing +1 888 713 4217 (domestic) or +1 617 213 4869
(international) and entering access code 55195099, a few minutes
before 11:30 a.m. ET on May 1, 2009. The call will also be
broadcast live on the Internet at http://www.streetevents.com/,
http://www.fulldisclosure.com/ or http://www.scolr.com/. A replay
of the conference call will be accessible two hours after its
completion through May 15, 2009, by dialing +1 888 286 8010
(domestic) or +1 617 801 6888 (international) and entering access
code 86289597. The call will also be archived for 90 days at
http://www.streetevents.com/, http://www.fulldisclosure.com/ or
http://www.scolr.com/. About SCOLR Pharma: Based in Bothell,
Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical
company whose objective is to combine its formulation expertise and
its patented CDT platforms to develop novel prescription
pharmaceutical, over-the-counter (OTC), and nutritional products.
Our CDT drug delivery platforms are based on multiple issued and
pending patents and other intellectual property for the programmed
release or enhanced performance of active pharmaceutical
ingredients and nutritional products. For more information on SCOLR
Pharma, please call 425.368.1050 or visit http://www.scolr.com/.
Contact: Investor Relations: Cameron Associates Kevin McGrath
212.245.4577 DATASOURCE: SCOLR Pharma, Inc. CONTACT: Investor
Relations, Kevin McGrath of Cameron Associates, +1-212-245-4577, ,
for SCOLR Pharma, Inc. Web Site: http://www.scolr.com/
Copyright